Analysen zu GSK PLC Registered Shs
| 01.08.24 | GSK Halten | DZ BANK | |
| 01.08.24 | GSK Buy | Deutsche Bank AG | |
| 01.08.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 01.08.24 | GSK Neutral | UBS AG | |
| 31.07.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 31.07.24 | GSK Buy | Deutsche Bank AG | |
| 31.07.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 29.07.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 25.07.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 24.07.24 | GSK Buy | Jefferies & Company Inc. | |
| 10.07.24 | GSK Buy | Deutsche Bank AG | |
| 08.07.24 | GSK Neutral | UBS AG | |
| 04.07.24 | GSK Buy | Deutsche Bank AG | |
| 04.07.24 | GSK Buy | UBS AG | |
| 02.07.24 | GSK Buy | Jefferies & Company Inc. | |
| 02.07.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.07.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 27.06.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 27.06.24 | GSK Buy | UBS AG | |
| 19.06.24 | GSK Buy | Deutsche Bank AG | |
| 18.06.24 | GSK Buy | UBS AG | |
| 18.06.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 18.06.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 17.06.24 | GSK Buy | Jefferies & Company Inc. | |
| 10.06.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 07.06.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 04.06.24 | GSK Halten | DZ BANK | |
| 04.06.24 | GSK Buy | UBS AG | |
| 04.06.24 | GSK Buy | Deutsche Bank AG | |
| 03.06.24 | GSK Buy | Jefferies & Company Inc. | |
| 03.06.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 03.06.24 | GSK Buy | Deutsche Bank AG | |
| 03.06.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 30.05.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 13.05.24 | GSK Buy | Deutsche Bank AG | |
| 13.05.24 | GSK Buy | Jefferies & Company Inc. | |
| 08.05.24 | GSK Outperform | Bernstein Research | |
| 06.05.24 | GSK Buy | UBS AG | |
| 03.05.24 | GSK Halten | DZ BANK | |
| 02.05.24 | GSK Buy | Deutsche Bank AG | |
| 02.05.24 | GSK Buy | UBS AG | |
| 02.05.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.05.24 | GSK Buy | UBS AG | |
| 01.05.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 29.04.24 | GSK Buy | UBS AG | |
| 24.04.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 24.04.24 | GSK Outperform | Bernstein Research | |
| 08.04.24 | GSK Equal Weight | Barclays Capital | |
| 04.04.24 | GSK Equal Weight | Barclays Capital | |
| 03.04.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
Aktuelle Aktienanalysen
| 16.01.26 | Deutsche Telekom Overweight | Barclays Capital | |
| 16.01.26 | Vodafone Group Overweight | Barclays Capital | |
| 16.01.26 | 1&1 Equal Weight | Barclays Capital | |
| 16.01.26 | ASML NV Outperform | Bernstein Research | |
| 16.01.26 | Schoeller-Bleckmann accumulate | Erste Group Bank | |
| 16.01.26 | Grand City Properties Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.01.26 | Shell Overweight | Barclays Capital | |
| 16.01.26 | Klöckner Sell | Warburg Research | |
| 16.01.26 | Fraport Hold | Jefferies & Company Inc. | |
| 16.01.26 | adidas Buy | UBS AG | |
| 16.01.26 | Richemont Overweight | Barclays Capital | |
| 16.01.26 | Münchener Rückversicherungs-Gesellschaft Overweight | Barclays Capital | |
| 16.01.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 16.01.26 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.01.26 | BP Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.01.26 | Richemont Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.01.26 | Jungheinrich Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.01.26 | AXA Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.01.26 | Merck Overweight | JP Morgan Chase & Co. | |
| 16.01.26 | Pernod Ricard Neutral | JP Morgan Chase & Co. | |
| 16.01.26 | Henkel vz. Underweight | JP Morgan Chase & Co. | |
| 16.01.26 | AB InBev Overweight | JP Morgan Chase & Co. | |
| 16.01.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 16.01.26 | Danone Overweight | JP Morgan Chase & Co. | |
| 16.01.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 16.01.26 | Beiersdorf Overweight | JP Morgan Chase & Co. | |
| 16.01.26 | L'Oréal Neutral | JP Morgan Chase & Co. | |
| 16.01.26 | JCDecaux Neutral | JP Morgan Chase & Co. | |
| 16.01.26 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 16.01.26 | Stellantis Overweight | JP Morgan Chase & Co. | |
| 16.01.26 | Givaudan Overweight | Barclays Capital | |
| 16.01.26 | Akzo Nobel Overweight | Barclays Capital | |
| 16.01.26 | Air Liquide Overweight | Barclays Capital | |
| 16.01.26 | Symrise Equal Weight | Barclays Capital | |
| 16.01.26 | WACKER CHEMIE Equal Weight | Barclays Capital | |
| 16.01.26 | Evonik Equal Weight | Barclays Capital | |
| 16.01.26 | BASF Equal Weight | Barclays Capital | |
| 16.01.26 | LANXESS Underweight | Barclays Capital | |
| 16.01.26 | Brenntag Equal Weight | Barclays Capital | |
| 15.01.26 | Drägerwerk vz. Hold | Jefferies & Company Inc. | |
| 15.01.26 | Richemont Overweight | JP Morgan Chase & Co. | |
| 15.01.26 | Richemont Buy | UBS AG | |
| 15.01.26 | RWE Overweight | Barclays Capital | |
| 15.01.26 | Richemont Outperform | Bernstein Research | |
| 15.01.26 | Heidelberg Materials Buy | Deutsche Bank AG | |
| 15.01.26 | Beiersdorf Outperform | Bernstein Research | |
| 15.01.26 | Carl Zeiss Meditec Outperform | Bernstein Research | |
| 15.01.26 | AstraZeneca Overweight | Barclays Capital | |
| 15.01.26 | GSK Underweight | Barclays Capital | |
| 15.01.26 | Novartis Equal Weight | Barclays Capital |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.